Targeting the DNA repair defect of BRCA tumours

Current Opinion in Pharmacology

Volumn 5, Issue 4 SPEC. ISS., 2005, Pages 388-393

  Turner, Nicholas ^a   Tutt, Andrew ^a   Ashworth, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CARBOPLATIN; CISPLATIN; DOCETAXEL; MITOMYCIN C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ALLELE; BREAST CANCER; CANCER SUSCEPTIBILITY; DNA REPAIR; DNA STRAND BREAKAGE; DRUG TARGETING; GENE MUTATION; HETEROZYGOSITY; HOMOLOGOUS RECOMBINATION; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR GROWTH;

EID: 21644482340     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.03.006     Document Type: Review

References (50)

1. R. Wooster B.L. Weber Breast and ovarian cancer N Engl J Med 348 2003 2339-2347
2. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171-182
3. A. Tutt A. Ashworth The relationship between the roles of BRCA genes in DNA repair and cancer predisposition Trends Mol Med 8 2002 571-576
4. M.J. Daniels Y. Wang M. Lee A.R. Venkitaraman Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2 Science 306 2004 876-879
5. M.E. Moynahan J.W. Chiu B.H. Koller M. Jasin Brca1 controls homology-directed DNA repair Mol Cell 4 1999 511-518
6. M.E. Moynahan A.J. Pierce M. Jasin BRCA2 is required for homology-directed repair of chromosomal breaks Mol Cell 7 2001 263-272
7. A. Tutt D. Bertwistle J. Valentine A. Gabriel S. Swift G. Ross C. Griffin J. Thacker A. Ashworth Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences EMBO J 20 2001 4704-4716
8. A.R. Lehmann The role of SMC proteins in the responses to DNA damage DNA Repair (Amst) 4 2005 309-314
9. B. Elliott M. Jasin Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells Mol Cell Biol 21 2001 2671-2682
10. D. Cortez Y. Wang J. Qin S.J. Elledge Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks Science 286 1999 1162-1166
11. R.S. Tibbetts D. Cortez K.M. Brumbaugh R. Scully D. Livingston S.J. Elledge R.T. Abraham Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress Genes Dev 14 2000 2989-3002
12. J.S. Lee K.M. Collins A.L. Brown C.H. Lee J.H. Chung hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response Nature 404 2000 201-204
13. Y. Wang D. Cortez P. Yazdi N. Neff S.J. Elledge J. Qin BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev 14 2000 927-939
14. Q. Zhong C.F. Chen S. Li Y. Chen C.C. Wang J. Xiao P.L. Chen Z.D. Sharp W.H. Lee Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response Science 285 1999 747-750
15. T.T. Paull D. Cortez B. Bowers S.J. Elledge M. Gellert Direct DNA binding by Brca1 Proc Natl Acad Sci USA 98 2001 6086-6091
16. D.P. Harkin J.M. Bean D. Miklos Y.H. Song V.B. Truong C. Englert F.C. Christians L.W. Ellisen S. Maheswaran J.D. Oliner et al. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 97 1999 575-586
17. L. Pellegrini D.S. Yu T. Lo S. Anand M. Lee T.L. Blundell A.R. Venkitaraman Insights into DNA recombination from the structure of a RAD51-BRCA2 complex Nature 420 2002 287-293
18. D.S. Yu E. Sonoda S. Takeda C.L. Huang L. Pellegrini T.L. Blundell A.R. Venkitaraman Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2 Mol Cell 12 2003 1029-1041
19. H. Yang Q. Li J. Fan W.K. Holloman N.P. Pavletich The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction Nature 433 2005 653-657
20. J.M. Stark A.J. Pierce J. Oh A. Pastink M. Jasin Genetic steps of mammalian homologous repair with distinct mutagenic consequences Mol Cell Biol 24 2004 9305-9316
21. Q. Zhong T.G. Boyer P.L. Chen W.H. Lee Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts Cancer Res 62 2002 3966-3970
22. H. Wang Z.C. Zeng T.A. Bui S.J. DiBiase W. Qin F. Xia S.N. Powell G. Iliakis Nonhomologous end-joining of ionizing radiation-induced DNA double- stranded breaks in human tumor cells deficient in BRCA1 or BRCA2 Cancer Res 61 2001 270-277
23. A.R. Hartman J.M. Ford BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair Nat Genet 32 2002 180-184
24. A.D. D'Andrea M. Grompe The Fanconi anaemia/BRCA pathway Nat Rev Cancer 3 2003 23-34
25. A.R. Meetei J.P. de Winter A.L. Medhurst M. Wallisch Q. Waisfisz H.J. van de Vrugt A.B. Oostra Z. Yan C. Ling C.E. Bishop et al. A novel ubiquitin ligase is deficient in Fanconi anemia Nat Genet 35 2003 165-170
26. I. Garcia-Higuera T. Taniguchi S. Ganesan M.S. Meyn C. Timmers J. Hejna M. Grompe A.D. D'Andrea Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway Mol Cell 7 2001 249-262
27. S. Hussain J.B. Wilson A.L. Medhurst J. Hejna E. Witt S. Ananth A. Davies J.Y. Masson R. Moses S.C. West et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways Hum Mol Genet 13 2004 1241-1248
28. N.G. Howlett T. Taniguchi S. Olson B. Cox Q. Waisfisz C. De Die-Smulders N. Persky M. Grompe H. Joenje G. Pals et al. Biallelic inactivation of BRCA2 in Fanconi anemia Science 297 2002 606-609
29. K. Yamamoto S. Hirano M. Ishiai K. Morishima H. Kitao K. Namikoshi M. Kimura N. Matsushita H. Arakawa J.M. Buerstedde et al. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination Mol Cell Biol 25 2005 34-43
30. K. Nakanishi Y.G. Yang A.J. Pierce T. Taniguchi M. Digweed A.D. D'Andrea Z.Q. Wang M. Jasin et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair Proc Natl Acad Sci USA 102 2005 1110-1115
31. M. Santarosa A. Ashworth Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way Biochim Biophys Acta 1654 2004 105-122
32. M. Kraakman-van der Zwet W.J. Overkamp R.E. van Lange J. Essers A. van Duijn-Goedhart I. Wiggers S. Swaminathan P.P. van Buul A. Errami R.T. Tan et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions Mol Cell Biol 22 2002 669-679
33. A. Bhattacharyya U.S. Ear B.H. Koller R.R. Weichselbaum D.K. Bishop The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin J Biol Chem 275 2000 23899-23903
34. A. Rothfuss M. Grompe Repair kinetics of genomic interstrand DNA cross-links: Evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway Mol Cell Biol 24 2004 123-134
35. W. Niedzwiedz G. Mosedale M. Johnson C.Y. Ong P. Pace K.J. Patel The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair Mol Cell 15 2004 607-620
36. A. Tutt F. Connor D. Bertwistle P. Kerr J. Peacock G. Ross A. Ashworth Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity Oncogene 22 2003 2926-2931
37. J.E. Quinn R.D. Kennedy P.B. Mullan P.M. Gilmore M. Carty P.G. Johnston D.P. Harkin BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis Cancer Res 63 2003 6221-6228
38. J. Couzin Choices - and uncertainties - for women with BRCA mutations Science 302 2003 592
39. H. Farmer N. McCabe C.J. Lord A.N. Tutt D.A. Johnson T.B. Richardson et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 2005 917-921
40. H.E. Bryant N. Schultz H.D. Thomas K.M. Parker D. Flower E. Lopez et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913-917
41. N. Turner A. Tutt A. Ashworth Hallmarks of 'BRCAness' in sporadic cancers Nat Rev Cancer 4 2004 814-819
42. J.C. Rice H. Ozcelik P. Maxeiner I. Andrulis B.W. Futscher Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens Carcinogenesis 21 2000 1761-1765
43. R.L. Baldwin E. Nemeth H. Tran H. Shvartsman I. Cass S. Narod B.Y. Karlan BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study Cancer Res 60 2000 5329-5333
44. T. Taniguchi M. Tischkowitz N. Ameziane S.V. Hodgson C.G. Mathew H. Joenje S.C. Mok A.D. D'Andrea Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 2003 568-574
45. L. Hughes-Davies D. Huntsman M. Ruas F. Fuks J. Bye S.F. Chin J. Milner L.A. Brown F. Hsu B. Gilks et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer Cell 115 2003 523-535
46. S. Staff J. Isola M. Tanner Haplo-insufficiency of BRCA1 in sporadic breast cancer Cancer Res 63 2003 4978-4983
47. N. Collins R. Wooster M.R. Stratton Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers Br J Cancer 76 1997 1150-1156
48. J.L. Hilton J.P. Geisler J.A. Rathe M.A. Hattermann-Zogg B. DeYoung R.E. Buller Inactivation of BRCA1 and BRCA2 in ovarian cancer J Natl Cancer Inst 94 2002 1396-1406
49. J. Milner B. Ponder L. Hughes-Davies M. Seltmann T. Kouzarides Transcriptional activation functions in BRCA2 Nature 386 1997 772-773
50. Y. Liu J.Y. Masson R. Shah P. O'Regan S.C. West RAD51C is required for Holliday junction processing in mammalian cells Science 303 2004 243-246